This is such great news!
Studies presented Friday at the San Antonio Breast Cancer Symposium showed new drug combinations are helping survival rates in women with early breast cancer!
The first test of cancer medications Herceptin and Tykerb together for early-stage disease doubled the number of women whose cancer disappeared compared to those who had only one of the drugs.
They aim at a protein called HER-2 that is overproduced in about one-fourth of all breast cancers. Herceptin blocks the protein on the cell's surface, while Tykerb does it inside the cell
In a test with 455 participants, just over half of the women who received Herceptin and Tykerb were discovered to have no signs of invasive cancer when their surgeries were done, versus only 25 to 30 percent of those given just one of these drugs.
The only drawback is the cost of these drugs together. Herceptin costs more than $4,000 a month, while Tykerb costs between $5,000 and $6,000 a month, PLUS the cost of doctors to infuse the medication.
Any progress fighting cancer is fantastic news, regardless of cost!
[Image via Getty Images.]